Experiences of cancer survivors with chemotherapy-induced peripheral neuropathy in the Netherlands: symptoms, daily limitations, involvement of healthcare professionals, and social support
- PMID: 37221391
- PMCID: PMC11424700
- DOI: 10.1007/s11764-023-01402-4
Experiences of cancer survivors with chemotherapy-induced peripheral neuropathy in the Netherlands: symptoms, daily limitations, involvement of healthcare professionals, and social support
Abstract
Purpose: A significant proportion of cancer patients suffer from chemotherapy-induced peripheral neuropathy (CIPN). This descriptive study aimed to examine patients' experience of CIPN symptoms, daily limitations, involvement of healthcare professionals, and social support.
Methods: Cross-sectional data have been collected in the Netherlands via a national online questionnaire comprising closed items only (February 2021).
Results: Out of 3752 respondents, 1975 received chemotherapy only (i.e., without targeted therapy) and were therefore included. The majority (71.2%) reported symptoms in both hands and feet (e.g., tingling and loss of sensation or diminished sensation). Participants reported most limitations in household chores, social activities, hobbies, sports, walking, and sleeping and least in family/(taking care of) children, cycling, driving, self-care, eating and drinking, and sexuality and intimacy. Many patients indicated that their healthcare professionals informed them about the possibility of CIPN development before treatment (58.4%), and they paid attention to CIPN during and after treatment (53.1%). However, many patients (43%) reported a lack of information on what to do when CIPN develops. Few participants (22%) visited their general practitioner (GP) for CIPN. In general, patients' social environments sometimes to always showed empathy to patients.
Conclusions: Symptoms of CIPN are frequently reported and can result in various daily limitations. Support from professionals and peers is crucial in managing CIPN, which is sometimes lacking. Appropriate guidance and support should be provided to patients to decrease the impact of CIPN on daily life. Future research should investigate differences in chemotherapeutic agents and the resulting symptoms and consequences.
Keywords: Chemotherapy-induced peripheral neuropathy; Daily limitations; Healthcare professionals; Self-reported; Social support; Symptoms.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.Support Care Cancer. 2020 Dec;28(12):5933-5941. doi: 10.1007/s00520-020-05438-5. Epub 2020 Apr 12. Support Care Cancer. 2020. PMID: 32281032 Free PMC article.
-
Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.Support Care Cancer. 2019 Oct;27(10):3905-3912. doi: 10.1007/s00520-019-04695-3. Epub 2019 Feb 15. Support Care Cancer. 2019. PMID: 30770977 Free PMC article.
-
Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.BMC Cancer. 2019 Sep 10;19(1):904. doi: 10.1186/s12885-019-6113-3. BMC Cancer. 2019. PMID: 31506070 Free PMC article.
-
Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments.Ann Palliat Med. 2025 Mar;14(2):196-216. doi: 10.21037/apm-24-154. Ann Palliat Med. 2025. PMID: 40211744 Review.
-
The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12443. Epub 2016 Jan 20. Eur J Cancer Care (Engl). 2017. PMID: 26786536 Review.
Cited by
-
Coping with and self-management of chronic painful chemotherapy-induced peripheral neuropathy: a qualitative study among cancer survivors.J Cancer Surviv. 2025 Feb;19(1):295-305. doi: 10.1007/s11764-023-01466-2. Epub 2023 Sep 23. J Cancer Surviv. 2025. PMID: 37740129 Free PMC article.
-
Recent Advances in Diagnosis, Management, Treatment, and Prevention of Neuropathies in Cancer Patients.Curr Neurol Neurosci Rep. 2025 Jun 20;25(1):42. doi: 10.1007/s11910-025-01429-3. Curr Neurol Neurosci Rep. 2025. PMID: 40540116 Review.
-
Relationship between chemotherapy-induced peripheral neuropathy and physical activity in cancer survivors: A prospective longitudinal study.Asia Pac J Oncol Nurs. 2024 May 11;11(7):100507. doi: 10.1016/j.apjon.2024.100507. eCollection 2024 Jul. Asia Pac J Oncol Nurs. 2024. PMID: 39022773 Free PMC article.
-
A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): Protocol for a phase I feasibility trial.PLoS One. 2025 Apr 29;20(4):e0322371. doi: 10.1371/journal.pone.0322371. eCollection 2025. PLoS One. 2025. PMID: 40299845 Free PMC article.
References
-
- Integraal Kankercentrum Nederland. Nederlandse Kankerregistratie [Internet]. 2021. www.iknl.nl/nkr-cijfers
-
- Integraal Kankercentrum Nederland. Cancer patient survival increases, but not across all cancers [Overleving kankerpatiënten stijgt, maar niet bij alle kankersoorten] [Internet]. 2022. https://iknl.nl/nieuws/2022/overleving-kankerpatienten-stijgt,-maar-niet...
-
- Mols F, Beijers T, Vreugdenhil G, et al. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22:2261–9. 10.1007/s00520-014-2255-7. - PubMed
-
- Foster C, Wright D, …, HH-E journal of, et al. Psychosocial implications of living 5 years or more following a cancer diagnosis: a systematic review of the research evidence. Wiley Online Libr. 2009;18:223–247. 10.1111/j.1365-2354.2008.01001.x. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical